在冠状动脉疾病的诊断和治疗方面的创新
Salaheldin Agamy1, Sheref Zaghloul2, Zahid Khan3
1Cardiology Department, University Hospitals Birmingham, Hartlands Hospital, Birmingham B15 2GW, UK.
Diagnostics (Basel, Switzerland)
|January 10, 2026
概括
冠状动脉疾病 (CAD) 诊断和治疗的最新进展包括改进的成像,新的支架和向治疗. 需要进一步的研究来早期检测易受损伤的斑块,以减少全球CAD的负担.
科学领域:
- 心脏病学 心脏病学
- 医疗技术 医疗技术 医学技术
- 药理学 药理学是指药理学的学科.
背景情况:
- 冠状动脉疾病 (CAD) 是一个重大的全球健康和经济挑战.
- 该审查涉及CAD对全球个人和医疗保健系统的重大负担.
研究的目的:
- 为最近在CAD诊断,干预和药物管理方面的进展提供全面的概述.
- 突出那些正在塑造CAD护理未来的新兴技术.
主要方法:
- 一个叙述性的综述综合了临床试验,系统性审查,元分析和临床前研究的数据.
- 文献搜索侧重于2010年1月至2025年12月期间发表的文章.
主要成果:
- 非侵入性成像 (例如PCAT) 和FFR技术增强了早期CAD检测. 高灵敏度的热素改善了急性冠状动脉综合征的诊断.
- 新一代药物排泄支架 (DES) 和机器人辅助皮肤冠状动脉干预 (PCI) 改善了干预结果. 药物涂层气球 (DCBs) 对各种类型的病变具有前景.
- 纳米医学和3D生物打印容器代表了未来的治疗途径. 现代药物治疗是实现胆固醇目标的关键.
结论:
- 在CAD诊断,干预和药物治疗方面取得了重大进展.
- 在症状前确定易受伤害的动脉瘤仍然存在挑战,需要验证的生物标志物和成像.
- 持续的研究对于改善患者的治疗结果和减轻CAD的全球影响至关重要.
相关概念视频
Coronary Artery Disease V: Interprofessional Care
210
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
210
Coronary Artery Disease I: Introduction
869
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
869
Coronary Artery Disease IV: Preventive Measures
580
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
580
Acute Coronary Syndrome IV: Interprofessional Care
214
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
214
Angina IV: Management
232
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
232
Acute Coronary Syndrome III: Diagnostic Studies
207
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
207


